Foxwayne Enterprises Acquisition Corp. does not have significant business. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Foxwayne Enterprises Acquisition Corp. was incorporated in 2020 and is based in New York, New York.
IPO Year: 2021
Exchange: NASDAQ
Website: foxwayne.com
| Date | Price Target | Rating | Analyst |
|---|
Fastest customizable press release news feed in the world
NEW YORK, Nov. 29, 2022 /PRNewswire/ -- FoxWayne Enterprises Acquisition Corp. ("FoxWayne" or the "Company") (Nasdaq: "FOXW", "FOXWU", "FOXWW") announced today that its special meeting of stockholders (the "Special Meeting") originally scheduled for Wednesday, November 30, 2022, is being postponed to Tuesday December 13, 2022. At the Special Meeting, stockholders will be asked to vote on the following proposals: (1) a proposal to approve an amendment (the "Extension Amendment") to the Company's Second Amended and Restated Certificate of Incorporation to extend the date by which the Company must consummate a business combination for three months, from January 22, 2023 (the "Original Terminati
New entity poised to accelerate the development of Clover's next generation platform for live streaming with a suite of new product introductions. Clover has a growing user base of over 9 million with almost 90% of users between 18-39 years old. Clover is targeting a launch of VR ('Virtual Reality') Dating and VR Live Streaming in Q4 2023. NEW YORK, Sept. 20, 2022 /PRNewswire/ -- Clover Inc. ("Clover" or the "Company"), a highly rated live streaming company focused on Gen Z and Millennial audiences and creators, and FoxWayne Enterprises Acquisition Corp. (NASDAQ: FOXW, FOXWW) ("FoxWayne"), a special purpose acquisition company ("SPAC"), today announced they have entered into a definitive bu
DURHAM, N.C. and NEW YORK, March 4, 2022 /PRNewswire/ -- Aerami Therapeutics Holdings, Inc. ("Aerami"), a biopharmaceutical company focused on developing inhaled therapies to treat severe respiratory and chronic diseases, and FoxWayne Enterprises Acquisition Corp. (NASDAQ:FOXW) ("FoxWayne"), a publicly traded special purpose acquisition company ("SPAC"), announced today that they have mutually agreed to terminate their previously announced business combination agreement, effective immediately. In light of current unfavorable market conditions, Aerami and FoxWayne believe that
15-12G - FoxWayne Enterprises Acquisition Corp. (0001829999) (Filer)
25-NSE - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
425 - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
8-K - FoxWayne Enterprises Acquisition Corp. (0001829999) (Filer)
425 - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
8-K - FoxWayne Enterprises Acquisition Corp. (0001829999) (Filer)
DEFA14A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Filer)
DEF 14A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Filer)
PRE 14A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Filer)
DEFA14A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G/A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G/A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G/A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G/A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G/A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G/A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)
SC 13G/A - FoxWayne Enterprises Acquisition Corp. (0001829999) (Subject)